Serial Number | 90275578 |
Word Mark | STILLWATER PROGRAM |
Filing Date | Friday, October 23, 2020 |
Status | 733 - FOURTH EXTENSION - GRANTED |
Status Date | Friday, July 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 24, 2022 |
Description of Mark | The mark consists of a stylized yellow sun over three horizontal blue lines all atop the stylized word "STILLWATER" in blue which is above the stylized word "PROGRAM" in blue. |
Indication of Colors claimed | The color(s) yellow and blue is/are claimed as a feature of the mark. |
Goods and Services | Providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders |
NOT AVAILABLE | "PROGRAM" |
Goods and Services | Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 14, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 14, 2020 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Neurocrine Biosciences, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Party Name | Neurocrine Biosciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Event Date | Event Description |
Monday, December 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 27, 2020 | NEW APPLICATION ENTERED |
Tuesday, December 15, 2020 | ASSIGNED TO EXAMINER |
Saturday, December 19, 2020 | NON-FINAL ACTION E-MAILED |
Saturday, December 19, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 21, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, December 15, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Saturday, December 19, 2020 | NON-FINAL ACTION WRITTEN |
Tuesday, June 22, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, June 21, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, July 26, 2021 | SUSPENSION LETTER WRITTEN |
Monday, July 26, 2021 | LETTER OF SUSPENSION E-MAILED |
Monday, July 26, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, February 22, 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Thursday, April 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, April 18, 2022 | ASSIGNED TO LIE |
Wednesday, May 4, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 24, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, May 24, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Friday, January 6, 2023 | SOU TEAS EXTENSION RECEIVED |
Friday, January 6, 2023 | SOU EXTENSION 1 FILED |
Friday, January 6, 2023 | SOU EXTENSION 1 GRANTED |
Wednesday, July 5, 2023 | SOU EXTENSION 2 GRANTED |
Tuesday, January 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, July 5, 2023 | SOU TEAS EXTENSION RECEIVED |
Wednesday, July 5, 2023 | SOU EXTENSION 2 FILED |
Friday, July 7, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, January 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, July 12, 2024 | SOU TEAS EXTENSION RECEIVED |
Friday, July 12, 2024 | SOU EXTENSION 4 FILED |
Friday, July 12, 2024 | SOU EXTENSION 4 GRANTED |
Tuesday, January 7, 2025 | SOU TEAS EXTENSION RECEIVED |
Friday, July 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, January 16, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, January 16, 2024 | SOU EXTENSION 3 FILED |
Tuesday, January 16, 2024 | SOU EXTENSION 3 GRANTED |